A Study to Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and Morphine
Clinical trial NCT00472303 · COMPLETED
Trial details
- NCT number
- NCT00472303
- Sponsor
- Grünenthal GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2012-06-01
- Enrollment
- 622
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.